Marksans Pharma Limited has informed the Exchange regarding a press release dated October 15, 2025, titled "Marksans Pharma Ltd's wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its products from UK MHRA".
Marksans Pharma Limited has informed the Exchange regarding a press release dated October 15, 2025, titled "Marksans Pharma Ltd's wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its products from UK MHRA".